XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statement of Stockholders' Equity - USD ($)
$ in Thousands
Total
Capital stock
Capital in excess of par value
Retained earnings
Accumulated foreign currency adjustment attributable to parent
Accumulated defined benefit plans adjustment attributable to parent
Accumulated other comprehensive (loss) income
Treasury stock
Balance at the beginning of the year at Dec. 31, 2021   $ 2,689 $ 1,012,526 $ 7,900,113 $ (275,365) $ (195,079)   $ (1,573,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares issued   6            
Issuance of common stock under employee stock plans     5,898         3,019
Share-based compensation expense     22,527          
Net income $ 554,820     554,820        
Cash dividends paid       (101,197)        
Other       (1)        
Translation adjustments         (114,576)      
Change in long-term intercompany notes         (23,119)      
Net investment hedge instruments gain (loss), net of tax of $2,317 and $(13,777) for the quarter ended June 30, 2023 and 2022 and $6,122 and $(19,608) for the six months ended June 30, 2023 and 2022 , respectively         (60,209)      
Amortization of net actuarial loss and other, net of tax of $(518) and $(326) for the quarter ended June 30, 2023 and 2022 and $(1,036) and $(652) for the six months ended June 30, 2023 and 2022 , respectively           2,000    
Purchase of treasury stock               (331,379)
Balance at the end of the year at Jun. 30, 2022 6,950,091 2,695 1,040,951 8,353,735 (352,851) (193,079) $ (545,930) (1,901,360)
Balance at the beginning of the year at Mar. 31, 2022   2,693 1,018,433 8,121,781 (291,511) (194,079)   (1,725,629)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares issued   2            
Issuance of common stock under employee stock plans     9,562         (1,076)
Share-based compensation expense     12,956          
Net income 282,373     282,373        
Cash dividends paid       (50,419)        
Other       0        
Translation adjustments         (87,391)      
Change in long-term intercompany notes         (16,252)      
Net investment hedge instruments gain (loss), net of tax of $2,317 and $(13,777) for the quarter ended June 30, 2023 and 2022 and $6,122 and $(19,608) for the six months ended June 30, 2023 and 2022 , respectively         42,303      
Amortization of net actuarial loss and other, net of tax of $(518) and $(326) for the quarter ended June 30, 2023 and 2022 and $(1,036) and $(652) for the six months ended June 30, 2023 and 2022 , respectively           1,000    
Purchase of treasury stock               (174,655)
Balance at the end of the year at Jun. 30, 2022 6,950,091 2,695 1,040,951 8,353,735 (352,851) (193,079) (545,930) (1,901,360)
Balance at the beginning of the year at Dec. 31, 2022 7,476,512 2,700 1,094,236 8,857,485 (368,124) (206,821)   (1,902,964)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares issued   7            
Issuance of common stock under employee stock plans     6,824         13,860
Share-based compensation expense     22,860          
Net income 629,954     629,954        
Cash dividends paid       (115,071)        
Other       0        
Translation adjustments         62,660      
Change in long-term intercompany notes         5,903      
Net investment hedge instruments gain (loss), net of tax of $2,317 and $(13,777) for the quarter ended June 30, 2023 and 2022 and $6,122 and $(19,608) for the six months ended June 30, 2023 and 2022 , respectively         18,798      
Amortization of net actuarial loss and other, net of tax of $(518) and $(326) for the quarter ended June 30, 2023 and 2022 and $(1,036) and $(652) for the six months ended June 30, 2023 and 2022 , respectively           3,184    
Purchase of treasury stock               (6,524)
Balance at the end of the year at Jun. 30, 2023 8,081,371 2,707 1,123,920 9,372,368 (318,359) (203,637) (521,996) (1,895,628)
Balance at the beginning of the year at Mar. 31, 2023   2,704 1,092,362 9,105,705 (343,217) (205,229)   (1,895,200)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares issued   3            
Issuance of common stock under employee stock plans     18,977         (406)
Share-based compensation expense     12,581          
Net income 324,242     324,242        
Cash dividends paid       (57,579)        
Other       0        
Translation adjustments         29,840      
Change in long-term intercompany notes         2,132      
Net investment hedge instruments gain (loss), net of tax of $2,317 and $(13,777) for the quarter ended June 30, 2023 and 2022 and $6,122 and $(19,608) for the six months ended June 30, 2023 and 2022 , respectively         (7,114)      
Amortization of net actuarial loss and other, net of tax of $(518) and $(326) for the quarter ended June 30, 2023 and 2022 and $(1,036) and $(652) for the six months ended June 30, 2023 and 2022 , respectively           1,592    
Purchase of treasury stock               (22)
Balance at the end of the year at Jun. 30, 2023 $ 8,081,371 $ 2,707 $ 1,123,920 $ 9,372,368 $ (318,359) $ (203,637) $ (521,996) $ (1,895,628)